Nurse Practitioner, Family · Lebanon, NH
NPI
1871517524
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Medical Center Dr
Lebanon, NH, 03756
Phone (603) 650-5529
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
260 services
Medicare patients, 2024
117
Average age 75
Drug cost, 2024
$2.9M
592 prescriptions
Company payments, 2024
$21.31
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna D Schaal was code 99214 (office e&m - established), 119 times for 82 patients. In total Anna D Schaal billed 260 services in 6 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 119 | 82 | $56.38 | $6,709 |
| 99215 Office E&M - Established | Facility | 116 | 31 | $92.43 | $11K |
By year: 2022 $19K for 278 services; 2023 $16K for 235 services; 2024 $19K for 260 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna D Schaal prescribed most often to Medicare patients was Acyclovir, with 98 prescriptions and refills. In total Anna D Schaal wrote 592 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 98 | 113 | 20 | $1,129 |
| Sprycel Dasatinib | 50 | 50 | Under 11 | $215K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 48 | 57 | 11 | $222 |
| Pomalyst Pomalidomide | 34 | 34 | Under 11 | $661K |
| Imbruvica Ibrutinib | 30 | 30 | Under 11 | $480K |
| Revlimid Lenalidomide | 27 | 27 | 11 | $455K |
| Hydroxyurea Generic | 23 | 57 | Under 11 | $545 |
| Potassium Chloride Generic | 21 | 30 | Under 11 | $334 |
| Dasatinib Generic | 18 | 18 | Under 11 | $39K |
| Omeprazole Generic | 17 | 17 | Under 11 | $89.92 |
| Jakafi Ruxolitinib Phosphate | 17 | 17 | Under 11 | $271K |
| Calquence Acalabrutinib Maleate | 13 | 13 | Under 11 | $201K |
| Furosemide Generic | 13 | 21 | Under 11 | $28.92 |
| Duloxetine Hcl Generic | 11 | 15 | Under 11 | $136 |
| Fluconazole Generic | 11 | 11 | Under 11 | $496 |
Brand drugs: 211 claims; generic drugs: 381 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Anna D Schaal $21.31 ($21.31 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $21.31.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $21.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.